XBiotech Inc (NASDAQ: XBIT) stock enjoyed a major increase of 10.5% on 5/6/24. The shares closed at $9.38. This advance was accompanied by normal trading volume. The stock has risen 19.2% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
XBIT is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
XBiotech has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. XBiotech has a poor Appreciation Score of 16 but a very high Power Rating of 92, and the Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment